<?xml version="1.0" encoding="UTF-8"?>
<results title="mena-migration">
 <result pre="pristimerin can affect many tumor-related processes, such as apoptosis, autophagy," exact="migration" post="and invasion, vasculogenesis, and drug resistance. Various molecular targets"/>
 <result pre="clinic (Valastyan and Weinberg, 2011). Pristimerin was reported to inhibit" exact="migration" post="and invasion via targeting G protein signaling 4 (RGS4)"/>
 <result pre="be associated with its upstream Akt in pristimerin-induced inhibition of" exact="migration" post="and invasion in colorectal cancer HCT-116 cells (Yousef et"/>
 <result pre="EC109 cells in a dose-dependent manner, resulting in inhibition of" exact="migration" post="and invasion (Tu et al., 2018). To supply nutrients"/>
 <result pre="proliferation (Sun et al., 2017), differentiation (Wang et al., 2017)," exact="migration" post="(Tao et al., 2018) and apoptosis (Wang and Zhu,"/>
 <result pre="10.3892/or.2015.445726718323 YousefB. A.HassanH. M.GuerramM.HamdiA. M.WangB.ZhangL.-Y.et al. (2016b). Pristimerin inhibits proliferation," exact="migration" post="and invasion, and induces apoptosis in HCT-116 colorectal cancer"/>
</results>
